Matrix metallopeptidase 27 (MMP-27)

Matrix metallopeptidase 27 (MMP-27) is a member of the matrix metalloproteinase family of zinc-dependent endopeptidases, enzymes essential for the breakdown and remodeling of extracellular matrix components. Unlike classical secreted MMPs, MMP-27 has a unique C-terminal extension that functions as an intracellular retention signal, confining it to the endoplasmic reticulum rather than secretion to the extracellular space. MMP-27 is expressed in a range of tissues with highest levels in the liver, bone, kidney, stimulated B lymphocytes, and macrophages in the endometrium. It has a proposed role in the physiological remodeling of tissues during development, reproduction, and menstruation, and has been associated with disease states such as cancer, inflammatory conditions (including arthritis and endometriosis), and cardiovascular anomalies. Genetic variants of MMP-27 are linked to altered risk of recurrent pregnancy loss and may serve as reproductive biomarkers. The unique intracellular localization and regulation suggest that MMP-27 may have specialized functions distinct from other MMPs.

Other names

MMP27MMP-27matrix metalloproteinase 27

General class mechanisms for matrix metalloproteinase inhibitors: Competitive inhibition of the catalytic zinc-binding site; Blockade of extracellular matrix degradation activity (common for MMP inhibitors, but not necessarily validated for MMP-27 specifically); Intracellular retention: MMP-27 displays distinct intracellular localization, so typical extracellular blockade mechanisms may not apply.